Finding 979684 (2023-001)

-
Requirement
N
Questioned Costs
-
Year
2023
Accepted
2024-06-27

AI Summary

  • Core Issue: The Principal Investigator (PI) resigned without proper notification to the Grants Management Officer (GMO) or approval from the OPDIV for a replacement.
  • Impacted Requirements: Failure to comply with the requirement to inform the GMO and obtain OPDIV approval for changes in key personnel.
  • Recommended Follow-up: Establish a control system to ensure timely communication with the GMO and OPDIV regarding any changes in PI status.

Finding Text

2023-001 Congressional Directives Principal Investigator Cluster: Not applicable Grantor: U.S. Department of Health and Human Services Award Names: Congressional Directives Award Year: August 1, 2022 – July 31, 2025 Award Number: 1 CE1HS46621‐01‐00 Assistance Listing Number: 93.493 Pass-through entity: Not applicable Criteria The recipient is required to notify the Grants Management Officer (GMO) in writing if the Principal Investigator (PI)/Program or Project Director (PD) or key personnel specifically named in the Notice of Award (NoA) will withdraw from the project entirely, be absent from the project during any continuous period of 3 months or more, or reduce time devoted to the project by 25 percent or more from the level that was approved at the time of award (for example, a proposed change from 40 percent effort to 30 percent or less effort). The HHS Operating Divisions (OPDIV) must approve any alternate arrangement proposed by the recipient, including any replacement of the PI/PD or key personnel named in the NoA. Condition We noted the PI specifically named in the NoA resigned from the System in February 2023. Management identified a replacement of the PI to oversee the grant; however, management did not notify the GMO in writing that the PI would withdraw from the project and did not obtain approval from the OPDIV regarding the replacement. Cause Management did not have a control in place to notify the GMO and request approval from OPDIV upon the PI withdrawal from the grant. Effect The System was not in compliance with the requirement to notify the GMO and OPDIV of the change in the PI role. Questioned Costs None identified. Recommendation We recommend that management communicate with their GMO and OPDIV, as applicable, regarding this matter and implement a control that monitors the PIs assigned to each grant to ensure that they are notifying the GMO of any changes in status and obtaining approval from the OPDIV in a timely manner. Management’s View and Corrective Action Plan Management’s Views and Corrective Action Plan are included at the end of this report after the summary schedule of prior audit findings and status.

Categories

Subrecipient Monitoring

Other Findings in this Audit

Programs in Audit

ALN Program Name Expenditures
97.036 Disaster Grants - Public Assistance (presidentially Declared Disasters) $27.47M
93.498 Provider Relief Fund and American Rescue Plan (arp) Rural Distribution $6.49M
93.493 Congressional Directives $718,000
93.788 Opioid Str $193,853
21.027 Coronavirus State and Local Fiscal Recovery Funds $24,000